Key result
Pentoxifylline shows potential as a treatment for chronic heart failure by improving clinical symptoms and left ventricular function in small trials, though its exact mechanism remains unclear.
Why the study?
Does pentoxifylline improve clinical outcomes or surrogate markers in patients with chronic heart failure?
Population
Patients with chronic heart failure (CHF)
Design
Review
Authors
Loading...
May improve HF symptoms via non-TNF pathways; leaves open need for larger RCTs before practice change.
Does pentoxifylline improve clinical outcomes or surrogate markers in patients with chronic heart failure?
Pentoxifylline may provide clinical benefits in chronic heart failure through mechanisms independent of its putative TNF-alpha inhibition, warranting further investigation.
Shaw et al. (2009) conducted a review in Chronic heart failure. Pentoxifylline was evaluated. Pentoxifylline shows potential as a treatment for chronic heart failure by improving clinical symptoms and left ventricular function in small trials, though its exact mechanism remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: